About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
ISSN 2073–4034
eISSN 2414–9128
About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
Logout
2009№15 (189)
The Angiotensin-converting Enzyme Inhibitor Moexipril...

The Angiotensin-converting Enzyme Inhibitor Moexipril (moex) In The Treatment Of Arterial Hypertension

M.V. Leonova, O.A. Maneschina

The angiotensin-converting enzyme inhibitor moexipril (Moex) in the treatment of arterial hypertension
The angiotensin-converting enzyme Inhibitors (ACEI) remain one of the most popular classes of antihypertensive drugs. Moexipril is ACEI II generation with high antihypertensive effect, good safety profile, low incidence of side effects, metabolic neutrality, organoprotective effect, and have no adverse effects on bone metabolism. Moeksipril is one of few drugs with proved efficacy and safety in a special contingent - postmenopausal women with hypertension.

Keywords

hypertension
angiotensin converting enzyme
moeksipril
osteoporosis
Full text (in Russian)

Similar Articles

№1-2 / 2023
V.V. Salukhov, E.A. Kovalevskaya
The relationship between obesity, vitamin D deficiency and osteoporosis, as well as methods for their correction
№19 / 2017
E.A. Kulyaev (1), A.V. Grafov (1), O. V. Falameeva (1), V.S. Kholodkin (1), M.A Sadovoy (1, 2), O.V. Tsygankova (2)
EXPERIENCE OF THE USE OF ZOLEDRONIC ACID (REZOLLASTIN 5 MG/6.25 ML, OOO «NATIVA») IN PATIENTS WITH LOW BONE MINERAL DENSITY IN THE SETTINGS OF THE CENTER FOR PREVENTION OF OSTEOPOROSIS OF NOVOSIBIRSK SRITO
№6 / 2021
A.F. Subkhankulova (1), S.F. Subkhankulova (2)
Women’s health at an elegant age: the possibilities of menopausal hormone therapy
№2 / 2024
Dobrovolskaya O.V., Feklistov A.Yu., Kozyreva M.V., Demin N.V., Toroptsova N.V.
Osteoporosis and sarcopenia: association with nutritional status and physical performance in women with rheumatoid arthritis
№4 / 2024
Asanbaeva A.A., Brimkulov N.N.
On the issue of the prevalence of osteopenic syndrome in combination with COPD among residents of different altitudes of Kyrgyzstan
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.